Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vialsnews2021-12-06T13:43:09+00:00December 6th, 2021|Fierce Pharma|
AstraZeneca weighs spinning out COVID-19 products into separate company: Bloombergnews2021-12-06T11:22:47+00:00December 6th, 2021|Fierce Pharma|
Novartis’ Sandoz yanks one lot of deep vein thrombosis injectable after exposure to heat during shippingnews2021-12-03T17:44:02+00:00December 3rd, 2021|Fierce Pharma|
November sees Sanofi-Regeneron dethroned after 6-month rule over top TV ad spender listnews2021-12-03T16:39:52+00:00December 3rd, 2021|Fierce Pharma|
November sees Sanofi-Regeneron dethroned after 6-month rule over TV ad spender listnews2021-12-03T16:39:52+00:00December 3rd, 2021|Fierce Pharma|
Recordati to acquire EUSA Pharma for €750m, gaining 4 rare cancer drugsnews2021-12-03T16:20:53+00:00December 3rd, 2021|Fierce Pharma|
Bayer pads blockbuster case for Nubeqa with phase 3 win in metastatic prostate cancernews2021-12-03T15:52:17+00:00December 3rd, 2021|Fierce Pharma|
Fierce Pharma Asia—China’s insulin price cut; Astellas-Dyno gene therapy deal; Fujifilm’s U.K. investmentnews2021-12-03T15:10:47+00:00December 3rd, 2021|Fierce Pharma|
BioNTech CEO Sahin urges calm amid omicron’s spread, figures new vaccine will eventually be needed for variantnews2021-12-03T14:58:01+00:00December 3rd, 2021|Fierce Pharma|
AstraZeneca blocks investor group’s $7.6B buyout of rare disease specialist Sobi: reportnews2021-12-03T14:18:42+00:00December 3rd, 2021|Fierce Pharma|
